David P. LeBrun

2.6k total citations
67 papers, 1.8k citations indexed

About

David P. LeBrun is a scholar working on Pathology and Forensic Medicine, Molecular Biology and Oncology. According to data from OpenAlex, David P. LeBrun has authored 67 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Pathology and Forensic Medicine, 18 papers in Molecular Biology and 13 papers in Oncology. Recurrent topics in David P. LeBrun's work include Lymphoma Diagnosis and Treatment (26 papers), Software-Defined Networks and 5G (10 papers) and Acute Myeloid Leukemia Research (9 papers). David P. LeBrun is often cited by papers focused on Lymphoma Diagnosis and Treatment (26 papers), Software-Defined Networks and 5G (10 papers) and Acute Myeloid Leukemia Research (9 papers). David P. LeBrun collaborates with scholars based in Canada, United States and Belgium. David P. LeBrun's co-authors include Roger A. Warnke, Michael L. Cleary, Onsi W. Kamel, Douglas A. Dedera, Matt van de Rijn, Olivier Bonaventure, Gerald J. Berry, Eric Davis, Edmund K. Waller and Gregory S. Barsh and has published in prestigious journals such as Cell, Nucleic Acids Research and Journal of Biological Chemistry.

In The Last Decade

David P. LeBrun

64 papers receiving 1.8k citations

Peers

David P. LeBrun
Donald G. Morris Canada
Asha Das United States
Georgios Georgakis United States
Mithun Vinod Shah United States
G. Haroske Germany
Eric R. Christensen United States
Yutaka Kawakami Japan
Jeffrey Lin United States
Petar Stojanov United States
Eric J. Duncavage United States
Donald G. Morris Canada
David P. LeBrun
Citations per year, relative to David P. LeBrun David P. LeBrun (= 1×) peers Donald G. Morris

Countries citing papers authored by David P. LeBrun

Since Specialization
Citations

This map shows the geographic impact of David P. LeBrun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David P. LeBrun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David P. LeBrun more than expected).

Fields of papers citing papers by David P. LeBrun

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David P. LeBrun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David P. LeBrun. The network helps show where David P. LeBrun may publish in the future.

Co-authorship network of co-authors of David P. LeBrun

This figure shows the co-authorship network connecting the top 25 collaborators of David P. LeBrun. A scholar is included among the top collaborators of David P. LeBrun based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David P. LeBrun. David P. LeBrun is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chitayat, Seth, Kim Munro, George S. Baillie, et al.. (2020). Structural insights into TAZ2 domain–mediated CBP/p300 recruitment by transactivation domain 1 of the lymphopoietic transcription factor E2A. Journal of Biological Chemistry. 295(13). 4303–4315. 14 indexed citations
2.
3.
Crocker, Susan, et al.. (2018). High-grade B-cell lymphoma with MYC and BCL2 rearrangements arising in a composite lymphoma. Diagnostic Pathology. 13(1). 34–34.
4.
Chen, Bingshu E., Adnan Mansoor, David P. LeBrun, et al.. (2017). A bioclinical prognostic model using MYC and BCL2 predicts outcome in relapsed/refractory diffuse large B-cell lymphoma. Haematologica. 103(2). 288–296. 13 indexed citations
5.
Nanan, Kyster K., Patrick Thompson, Kathrin Tyryshkin, et al.. (2015). Retrovirus-Mediated Expression of E2A-PBX1 Blocks Lymphoid Fate but Permits Retention of Myeloid Potential in Early Hematopoietic Progenitors. PLoS ONE. 10(6). e0130495–e0130495. 2 indexed citations
6.
7.
Langelaan, David N., Seth Chitayat, Karen Munro, et al.. (2014). Functional redundancy between the transcriptional activation domains of E2A is mediated by binding to the KIX domain of CBP/p300. Nucleic Acids Research. 42(11). 7370–7382. 23 indexed citations
8.
Chitayat, Seth, Michael J. Plevin, Feng Wang, et al.. (2012). Structural basis of CBP/p300 recruitment in leukemia induction by E2A-PBX1. Blood. 120(19). 3968–3977. 34 indexed citations
9.
Farmer, Patricia, C. Blake Gilks, Julia Brettschneider, et al.. (2011). Differential expression of cell-cycle regulatory proteins defines distinct classes of follicular lymphoma. Human Pathology. 42(7). 972–982. 7 indexed citations
10.
Thompson, Patrick, et al.. (2011). Mapping acetylation sites in E2A identifies a conserved lysine residue in activation domain 1 that promotes CBP/p300 recruitment and transcriptional activation. Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms. 1819(5). 375–381. 11 indexed citations
11.
LeBrun, David P., et al.. (2010). Transplacental benzene exposure increases tumor incidence in mouse offspring: possible role of fetal benzene metabolism. Carcinogenesis. 31(6). 1142–1148. 24 indexed citations
12.
LeBrun, David P., Tara Baetz, Patricia Farmer, et al.. (2008). Predicting Outcome in Follicular Lymphoma by Using Interactive Gene Pairs. Clinical Cancer Research. 14(2). 478–487. 6 indexed citations
13.
Farmer, Patricia, Denis Bailey, Bruce F. Burns, Andrew G. Day, & David P. LeBrun. (2007). The Reliability of Lymphoma Diagnosis in Small Tissue Samples Is Heavily Influenced by Lymphoma Subtype. American Journal of Clinical Pathology. 128(3). 474–480. 25 indexed citations
14.
LeBrun, David P.. (2003). em E2 em A basic helix-loop-helix transcription factors in human leukemia. Frontiers in bioscience. 8(6). s206–222. 31 indexed citations
15.
LeBrun, David P., et al.. (2000). Role for Homodimerization in Growth Deregulation by E2a Fusion Proteins. Molecular and Cellular Biology. 20(16). 5789–5796. 13 indexed citations
16.
LeBrun, David P., et al.. (1997). The chimeric oncoproteins E2A-PBX1 and E2A-HLF are concentrated within spherical nuclear domains. Oncogene. 15(17). 2059–2067. 13 indexed citations
17.
Dedera, Douglas A., Mitsuyoshi Urashima, Dharminder Chauhan, et al.. (1996). Interleukin‐6 is Required for Pristane‐Induced Plasma Cell Hyperplasia In Mice. British Journal of Haematology. 94(1). 53–61. 20 indexed citations
18.
19.
Goates, Jeffrey J., Onsi W. Kamel, David P. LeBrun, Daniel Benharroch, & Ronald F. Dorfman. (1994). Floral Variant of Follicular Lymphoma. The American Journal of Surgical Pathology. 18(1). 37–47. 30 indexed citations
20.
Dedera, Douglas A., Edmund K. Waller, David P. LeBrun, et al.. (1993). Chimeric homeobox gene E2A-PBX1 induces proliferation, apoptosis, and malignant lymphomas in transgenic mice. Cell. 74(5). 833–843. 170 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Donald G. Morris Breakdown of academic impact, for papers by Asha Das Breakdown of academic impact, for papers by Georgios Georgakis Breakdown of academic impact, for papers by Mithun Vinod Shah Breakdown of academic impact, for papers by G. Haroske Breakdown of academic impact, for papers by Eric R. Christensen Breakdown of academic impact, for papers by Yutaka Kawakami Breakdown of academic impact, for papers by Jeffrey Lin Breakdown of academic impact, for papers by Petar Stojanov Breakdown of academic impact, for papers by Eric J. Duncavage
Rankless by CCL
2026